FRT [MARKET PERFORM -4.4%] - Improved profitability outlook for pharmacy business - Update
  • 2021-05-28T13:40:14
  • Company Research
We upgrade our rating from SELL to MARKET PERFORM as the path toward profitability of FRT’s Long Chau pharmacy chain is becoming clearer — particularly in terms of the positive progress in its opex optimization. In addition, FRT’s share price has corrected 7% in the last three months.